Nanome Webinar Series

The "Virtual" Reality of Drug Discovery at Novartis


Thursday, October 21st, 2021

8 am PST / 11 am EST

The "Virtual" Reality of Drug Discovery at Novartis

A conversation between Edgardo Leija, Chief Experience Officer at Nanome, and Wilian Cortopassi, Senior Expert in Data Science I (Principal Scientist I) at Novartis Institutes for BioMedical Research (NIBR).

Wilian Cortopassi

Wilian Cortopassi

Senior Expert in Data Science I (Principal Scientist I) at Novartis Institutes for BioMedical Research (NIBR)
Edgardo Leija

Edgardo Leija

Chief Experience Officer at Nanome

What will you learn?

Join our speakers for a discussion and Q&A about the "virtual" reality of drug discovery at Novartis:

 

  How Novartis is using Virtual Reality across different research sites globally (US and Switzerland)

   A case study of the main protease (Mpro) of SARS-CoV-2

  Future outlook of VR at Novartis

Upcoming Webinars

1615924123785

Jackie von Salm, PhD

Co-Founder & CSO, Psilera, Inc.

Wednesday, November 17, 2021
10 am PST / 1 pm EST

Details coming soon

Past Webinars

6abe93e5-a9d5-479a-8a9b-fb4c2da166ab_small

Woody Sherman

Chief Computational Scientist at Roivant Discovery, former CSO at Silicon Therapeutics

The Roivant Discovery vision for physics-driven drug design and the role of virtual reality to maximize insights.

Tuesday, August 24th, 2021
10 am PST / 1 pm EST

  What Roivant Discovery is doing with physics-driven drug design.

 The importance of structure-based drug discovery.

  Why VR is the next step to fully realize the benefit of structure-based drug discovery for visualization, collaboration, and design.

Request Recording of Webinar